SJS Investment Consulting »

Centessa Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2025-12-31 $376 15 25.07

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Eqt Etf (AVUS)
Hormel Foods Corporation (HRL)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Dimensional Etf Trust World Ex Us Core (DFAX)
NVIDIA Corporation (NVDA)

View all positions for SJS Investment Consulting

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
TCG Crossover Management
Siren
EcoR1 Capital
Perceptive Advisors
Franklin Resources
Federated Investors
First Light Asset Management
Braidwell

View all funds holding Centessa Pharmaceuticals